Durbin; Anna P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Durbin; Anna P..The latest application filed is for "live attenuated zika virus vaccine".

Company Profile

1.6.7

Durbin; Anna P. - Takoma Park MD
Durbin; Anna P. - Germantown MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Live Attenuated Zika Virus Vaccine App 20190194260 - Whitehead; Stephen S. ; et al.	2019-06-27
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences App 20120064569 - Murphy; Brian R. ; et al.	2012-03-15
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines Grant 7,632,508 - Schmidt , et al. December 15, 2	2009-12-15
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences App 20090081728 - Murphy; Brian R. ; et al.	2009-03-26
Attenuated parainfluenza virus (PIV) vaccines App 20080096264 - Murphy; Brian R. ; et al.	2008-04-24
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) Grant 7,314,631 - Murphy , et al. January 1, 2	2008-01-01
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences Grant 7,208,161 - Murphy , et al. April 24, 2	2007-04-24
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines Grant 7,201,907 - Schmidt , et al. April 10, 2	2007-04-10
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens Grant 7,192,593 - Murphy , et al. March 20, 2	2007-03-20
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines App 20060099226 - Schmidt; Alexander C. ; et al.	2006-05-11
Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences App 20050287540 - Murphy, Brian R. ; et al.	2005-12-29
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens App 20020155581 - Murphy, Brian R. ; et al.	2002-10-24
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene Grant 6,410,023 - Durbin , et al. June 25, 2	2002-06-25

Company Registrations

NCAGE Code	4N0X2	DURBIN ANNA P
CAGE Code	4N0X2	DURBIN, ANNA P

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.